Clarus Lifesciences III, L.P.'s Net Worth

-$3.79 Million

Who is Clarus Lifesciences III, L.P.?

Clarus Lifesciences III, L.P. does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Imago BioSciences, Inc., Talaris Therapeutics, Inc., Praxis Precision Medicines, Inc., ESSA Pharma Inc., GRAYBUG VISION, INC., Annexon, Inc., Gritstone Oncology, Inc., Entasis Therapeutics Holdings Inc., AVROBIO, Inc., and Forty Seven, Inc..

SEC CIK

Clarus Lifesciences III, L.P.'s CIK is 0001597143

Past Insider Trading and Trends

2018 was Clarus Lifesciences III, L.P.'s most active year for acquiring shares with 2 total transactions. Clarus Lifesciences III, L.P.'s most active month to acquire stocks was the month of August. 2018 was Clarus Lifesciences III, L.P.'s most active year for disposing of shares, totalling 2 transactions. Clarus Lifesciences III, L.P.'s most active month to dispose stocks was the month of September. 2018 saw Clarus Lifesciences III, L.P. paying a total of $4,999,995.00 for 2,567,445 shares, this is the most they've acquired in one year. In 2018 Clarus Lifesciences III, L.P. cashed out on 2,234,112 shares for a total of $0.00, their largest year based on trade value.